Refine by
Covid Preventive Vaccines Articles & Analysis
53 articles found
For a vaccine manufacturer contracted to fast-track production of COVID-19 vaccines, we designed and constructed a 700-square-foot Ultra-Low Temp storage ...
Custom mRNA production has emerged as a cutting-edge technology in the field of molecular biology, offering researchers the ability to tailor-make specific messenger RNA molecules for various applications such as vaccine development, gene therapy, and regenerative medicine. This innovative process holds great promise in unlocking new possibilities in scientific research, paving the way for ...
In recent years, mRNA vaccines have emerged as a revolutionary tool in the fight against infectious diseases, including the ongoing COVID-19 pandemic. These vaccines utilize messenger RNA (mRNA) to instruct cells to produce a protein that triggers an immune response, leading to the production of antibodies that protect against the targeted virus. While mRNA vaccines have shown remarkable efficacy ...
Introduction RNA Lipid Nanoparticles (LNP) technology has rapidly gained prominence in the health and scientific domain, primarily due to its significant role in carrying the mRNA of the COVID-19 vaccines developed by Pfizer/BioNTech and Moderna. Yet, the potential of this technology spans beyond the confines of these vaccines or even the health ...
The COVID-19 pandemic has killed millions of people. Vaccines certainly are the most outstanding ways to prevent major diseases and death, though they haven't eliminated infections. ...
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development. ...
Early in January 2020, sequencing revealed a novel coronavirus (now termed SARS-CoV-2) as the causal factor for the disease designated as COVID-19. The pandemic caused by the virus has unforeseen effects on the global economy and modern society, leading to a global race to find a suitable treatment and a preventive vaccine. SARS-CoV2 ...
ByNuvonis
Vaccine Freezers are required for the safe storage of vaccines that must be kept at extremely low temperatures. Without sufficient storage, a vaccine is likely to form deviations, drastically impacting the vaccines efficiency. At Froilabo we work to support the medical and pharmaceutical industry with the equipment they require to ensure safe storage solutions. Vaccine storage has been in high ...
COVID -19 Vaccine Overview The development of a COVID-19 vaccine by drug manufacturers has been welcomed across the globe. A key concern, however, is the safe distribution of the vaccines worldwide. This may cause some challenges for certain vaccines. ...
Polyethylene glycol (PEG) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or polyoxyethylene (POE), it has wide variety of applications depending on the length of the polymer chain and the molecular weight of the final polymer. The synthesis of PEG is done by polymerizing ethylene ...
But given that many are still hesitant to get vaccinated for COVID-19, it is apparent that we are amidst an ‘infodemic’. ...
Just as with any medical equipment out there or any vaccine, doctors, researchers, and transportation experts must know some things.Development From the very moment that they are developed, vaccines and the equipment there need to be monitored at all times, or in other words, the room needs to remain at a specific level of both temperature and humidity.This can be done through the following ...
ByUbiBot
Insilico Medicine announced the nomination of a novel preclinical therapeutic candidate for treating COVID-19, designed using the generative chemistry AI platform Chemistry42. The new drug candidate is a 3CL protease inhibitor unique from existing drugs in its class because it can be rapidly produced. While this nomination is a potentially important development for the ongoing COVID-19 pandemic ...
Polyethylene glycol (PEG) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or polyoxyethylene (POE), it has wide variety of applications depending on the length of the polymer chain and the molecular weight of the final polymer. The synthesis of PEG is done by polymerizing ethylene ...
From the eradication of smallpox through to the global response to the COVID-19 pandemic, vaccines have been a cornerstone in the fight against infectious diseases in humans and livestock since the 18th century. Although vaccines against COVID-19 are unlikely to eradicate the disease in the way that the smallpox ...
COVID-19 and viruses are a concern for all of us. Yet, anticipating a virus’s impact on an unborn child has heightened during the coronavirus pandemic for pregnant women or those expecting. However, there are tips you can take to protect yourself from viruses. ...
” The COVID-19 pandemic demonstrated the criticality of mRNA vaccines as a tool for quickly and effectively battling disease to improve lives around the world.And though several COVID-19 vaccines are now readily available, our work doesn’t stop there. ...
Several inhalation vaccines for COVID-19 are also on the horizon in the global fight against Omicron, and are expected to become another major weapon. ...
As the COVID-19 pandemic enters its third year, efforts to mitigate the risk of infection remain critical, especially for vulnerable populations. Recently, Andrea Edlow et al. of Massachusetts General Hospital published a study in the journal JAMA entitled "Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection". The study showed that ...
On February 16, 2022, the data on Paxlovid previously published by Pfizer and submitted to the FDA were published in the New England Journal of Medicine (NEJM). This NEJM article published viral load data that Paxlovid reduced viral load by 0.868 log10 compared to controls for 5 days of treatment, which equates to a remarkable 7.38-fold reduction in viral load. This pivotal study (NCT04960202) ...